查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2070476

臨床前影像市場規模、佔有率、成長、全球產業分析、區域趨勢及2026年至2034年預測。

Preclinical Imaging Market Size, Share, Growth, Global Industry Analysis, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 261 Pages | 商品交期: 2-3個工作天內

價格

臨床前影像市場的成長要素

全球臨床前影像市場預計在2025年達到34.2億美元，並從2026年的37.2億美元成長至2034年的68.5億美元，預測期內複合年成長率（CAGR）為8.0%。北美將在2025年引領市場，佔全球銷售額的40.64%。這主要得益於製藥業的強勁研發投入、先進的醫療基礎設施以及創新成像技術的日益普及。

臨床前影像是一種非侵入性成像技術，廣泛應用於藥物研發、疾病研究和轉譯醫學。該技術使研究人員能夠利用動物模型即時監測疾病進展、評估治療反應並研究生物過程。隨著癌症、糖尿病、心血管疾病和神經系統疾病等慢性疾病的日益普遍，製藥公司、生物技術公司、合約研究組織 (CRO) 和學術機構對先進影像解決方案的需求正在加速成長。

市場規模及預測

  • 2025年市場規模：34.2億美元
  • 2026年市場規模：37.2億美元
  • 2034年市場規模：68.5億美元
  • 複合年成長率（2026-2034年）：8.0%

該市場持續受益於藥物研發管線的擴張、生物醫學研究活動的活性化以及全球臨床前試驗投資的成長。

市場趨勢

先進光學成像技術的擴展

螢光成像和生物發光成像等先進光學成像技術在臨床前研究中日益重要。這些技術具有即時視覺化、高靈敏度和非侵入性監測等優點，是縱向研究的理想選擇。

隨著光學成像技術的應用日益廣泛，主要產業相關人員之間的策略性收購和合作也不斷推進。 2024年2月，布魯克收購了Spectral Instruments Imaging LLC，從而擴展了其臨床前成像產品組合，並增強了其在體內光學成像解決方案方面的能力。

市場促進因素

增加對藥物研發和生物醫學研究的投資

全球臨床前研究項目數量的不斷成長是市場擴張的主要驅動力。製藥和生物技術公司正在加大對早期藥物研發的投資，以發現新的療法並提高臨床成功率。

2025年1月，美國國立衛生研究院（NIH）在醫學研究舉措上投資了約480億美元。這些投資正在推動對成像平台的需求大幅成長，包括PET、SPECT、微型CT、微型MRI、超音波成像和光學成像系統。

對非侵入性成像技術日益成長的需求以及全球藥物研發活動的擴展，持續支持市場成長。

市場限制因素

設備和軟體高成本

儘管技術不斷進步，但先進成像系統的高成本仍然是一大障礙，尤其是在新興經濟體。先進的成像設備需要大量的資金投入，以及持續的維護、校準和軟體升級費用。

這些財務限制限制了小規模研究機構和醫療機構的採用，阻礙了其在發展中地區的市場滲透。

市場機遇

技術進步與人工智慧的融合

人工智慧 (AI)、多模態影像平台、先進影像重建和自動化分析工具的融合，正在為整個市場創造新的機會。

人工智慧驅動的醫學影像解決方案能夠提升數據解讀能力，加速研究工作流程，並增強轉化研究成果。各公司正加大新一代醫學影像技術的投資，這些技術具有更高的靈敏度、自動化程度和分析能力。

市場挑戰

發展中地區基礎設施匱乏

許多新興經濟體仍面臨醫療基礎設施不足、研究經費匱乏和專業人才短缺等挑戰。這些因素限制了先進臨床前影像系統的應用，並減緩了資源匱乏地區市場的擴張。

細分分析

按類型

市場區隔將市場分為硬體和軟體。

2025年，硬體領域成為市場成長的主要驅動力，這主要得益於科研機構對先進成像設備的廣泛應用。此外，主要廠商不斷推出新產品也持續推動了該領域的成長。

預計在預測期內，軟體領域將實現最快成長，複合年成長率達 8.5%，這主要得益於基於人工智慧的影像分析平台的日益普及。

用途別

市場區隔可分為以下幾個面向：

  • 腫瘤學
  • 循環系統
  • 神經病學
  • 感染疾病
  • 其他

預計到 2025 年，腫瘤領域將佔比最大，達到 38.3%，這主要得益於全球癌症負擔的加重和癌症研究投入的增加。

預計到 2034 年，循環系統產業將以 7.3% 的複合年成長率成長。

最終用戶

該市場包括：

  • 製藥和生物技術公司
  • 學術和研究機構
  • 合約研究組織（CRO）
  • 其他

預計到 2025 年，製藥和生物技術公司將成為市場的主要驅動力，並在 2026 年佔 42.4% 的市場佔有率，這主要得益於藥物研發投入的增加和成像技術的廣泛應用。

預計在預測期內，CRO 領域的複合年成長率將達到 8.8%。

區域展望

北美洲

北美仍然是最大的區域市場，預計到 2025 年將達到 13.9 億美元。製藥業的強勁創新、不斷成長的臨床研究活動以及先進的醫療保健基礎設施繼續支撐著該地區的領先地位。

美國

預計到 2026 年，美國市場規模將達到 13.5 億美元，約佔全球銷售額的 36.4%。

歐洲

預計2026年，歐洲市場規模將達到9.9億美元，複合年成長率為7.1%。強大的學術研究網路和政府支持的醫療創新計劃正在推動該地區的擴張。

亞太地區

受醫藥研發快速成長、醫療基礎設施發展和臨床試驗增加的推動，亞太地區預計到 2026 年將達到 8.9 億美元。

預計到 2026 年，中國市場規模將達到 2.9 億美元，而印度市場規模預計將達到 1 億美元。

拉丁美洲、中東和非洲

由於醫療保健領域的投資增加、研究活動的擴大以及先進醫療技術的普及，預計這兩個地區都將經歷穩定成長。

近期推出的產品、醫學影像軟體的進步以及人工智慧分析平台的出現，增強了整個產業的競爭力。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章：主要考慮因素

  • 2025年臨床試驗數量，主要國家和地區
  • 臨床前影像設備的技術進步
  • 新產品發布，主要公司
  • 產業重大發展：合併、收購與合作。

第5章：全球臨床前影像市場分析、洞察與預測（2021-2034年）

  • 市場分析、洞察與預測：按類型
    • 硬體
      • 裝置
      • 消耗品
    • 軟體
  • 市場分析、洞察與預測：按應用領域分類
    • 腫瘤學
    • 循環系統
    • 神經病學
    • 感染疾病
    • 其他
  • 市場分析、洞察與預測：按最終用戶分類
    • 製藥和生物技術公司
    • 學術研究機構
    • 合約研究組織（CRO）
    • 其他
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美臨床前影像市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲臨床前影像市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區臨床前影像市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 澳洲
    • 中國
    • 印度
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲臨床前影像市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲臨床前影像市場分析、洞察與預測（2021-2034年）

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • FUJIFILM Corporation
    • Bruker
    • Revvity
    • Mediso Ltd.
    • Siemens Healthineers
    • Miltenyi Biotec
    • MILabs BV
    • MR Solutions
    • Trifoil Imaging LLC
    • Aspect Imaging Ltd.
Product Code: FBI115617

Growth Factors of preclinical imaging Market

The global preclinical imaging market was valued at USD 3.42 billion in 2025 and is projected to grow from USD 3.72 billion in 2026 to USD 6.85 billion by 2034, registering a CAGR of 8.0% during the forecast period. North America dominated the market in 2025, accounting for 40.64% of global revenue, supported by strong pharmaceutical R&D investments, advanced healthcare infrastructure, and increasing adoption of innovative imaging technologies.

Preclinical imaging is a non-invasive imaging technique used extensively in drug discovery, disease research, and translational medicine. The technology enables researchers to monitor disease progression, evaluate therapeutic responses, and study biological processes in real time using animal models. Increasing prevalence of chronic diseases such as cancer, diabetes, cardiovascular disorders, and neurological diseases is accelerating demand for advanced imaging solutions across pharmaceutical companies, biotechnology firms, contract research organizations (CROs), and academic institutions.

Market Size and Forecast

  • 2025 Market Size: USD 3.42 Billion
  • 2026 Market Size: USD 3.72 Billion
  • 2034 Market Size: USD 6.85 Billion
  • CAGR (2026-2034): 8.0%

The market continues to benefit from expanding drug discovery pipelines, increasing biomedical research activities, and rising investments in preclinical studies worldwide.

Market Trends

Expansion of Advanced Optical Imaging Technologies

Advanced optical imaging technologies such as fluorescence imaging and bioluminescence imaging are becoming increasingly important in preclinical research. These technologies provide real-time visualization, high sensitivity, and non-invasive monitoring capabilities, making them ideal for longitudinal studies.

The growing adoption of optical imaging has encouraged strategic acquisitions and collaborations among major industry participants. In February 2024, Bruker expanded its preclinical imaging portfolio through the acquisition of Spectral Instruments Imaging LLC, strengthening its capabilities in in-vivo optical imaging solutions.

Market Drivers

Rising Investments in Drug Discovery and Biomedical Research

The growing number of preclinical research programs worldwide is a major factor driving market expansion. Pharmaceutical and biotechnology companies are increasing investments in early-stage drug development to identify novel therapies and improve clinical success rates.

In January 2025, the U.S. National Institutes of Health (NIH) invested approximately USD 48 billion in medical research initiatives. Such investments significantly increase demand for imaging platforms including PET, SPECT, micro-CT, micro-MRI, ultrasound imaging, and optical imaging systems.

Growing demand for non-invasive imaging technologies and expansion of global drug discovery activities continue to support market growth.

Market Restraints

High Equipment and Software Costs

Despite technological advancements, the high cost of sophisticated imaging systems remains a significant barrier, particularly in emerging economies. Advanced imaging instruments require substantial capital investment, along with ongoing maintenance, calibration, and software upgrade expenses.

These financial constraints limit adoption among smaller research institutions and healthcare facilities, thereby restricting market penetration in developing regions.

Market Opportunities

Technological Advancements and AI Integration

The integration of artificial intelligence, multimodal imaging platforms, advanced image reconstruction, and automated analysis tools is creating new opportunities across the market.

AI-powered imaging solutions improve data interpretation, accelerate research workflows, and enhance translational outcomes. Companies are increasingly investing in next-generation imaging technologies that offer higher sensitivity, automation, and analytical capabilities.

Market Challenges

Limited Infrastructure in Developing Regions

Many emerging countries continue to face challenges related to inadequate healthcare infrastructure, limited research funding, and shortages of skilled professionals. These factors restrict the widespread adoption of advanced preclinical imaging systems and slow market expansion in low-resource settings.

Segmentation Analysis

By Type

The market is segmented into hardware and software.

The hardware segment dominated the market in 2025 due to rising deployment of advanced imaging instruments across research facilities. Increasing product launches by leading manufacturers continue to strengthen this segment.

The software segment is expected to register the fastest growth with a CAGR of 8.5% during the forecast period, supported by increasing adoption of AI-based imaging analysis platforms.

By Application

The market is segmented into:

  • Oncology
  • Cardiology
  • Neurology
  • Infectious Diseases
  • Others

The oncology segment held the largest share of 38.3% in 2025, driven by the growing global cancer burden and increasing investments in oncology research.

The cardiology segment is projected to grow at a CAGR of 7.3% through 2034.

By End User

The market includes:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)
  • Others

The pharmaceutical and biotechnology companies segment dominated the market in 2025 and is expected to account for 42.4% market share in 2026, driven by increasing R&D expenditure and growing adoption of imaging technologies during drug development.

The CRO segment is anticipated to grow at a CAGR of 8.8% during the forecast period.

Regional Outlook

North America

North America remained the largest regional market, valued at USD 1.39 billion in 2025. Strong pharmaceutical innovation, increasing clinical research activities, and advanced healthcare infrastructure continue to support regional dominance.

United States

The U.S. market is expected to reach USD 1.35 billion in 2026, accounting for approximately 36.4% of global revenue.

Europe

Europe is projected to reach USD 0.99 billion in 2026, growing at a CAGR of 7.1%. Strong academic research networks and government-supported healthcare innovation programs are supporting regional expansion.

Asia Pacific

Asia Pacific is expected to reach USD 0.89 billion in 2026, driven by rapid growth in pharmaceutical research, healthcare infrastructure development, and increasing clinical studies.

China is projected to generate USD 0.29 billion in 2026, while India is expected to reach USD 0.10 billion.

Latin America and Middle East & Africa

Both regions are anticipated to witness steady growth due to increasing healthcare investments, expanding research activities, and improving access to advanced medical technologies.

Competitive Landscape

The market is highly competitive, with major companies focusing on product innovation, acquisitions, collaborations, and new technology launches.

Key companies operating in the market include:

  • FUJIFILM Corporation
  • Bruker
  • Revvity
  • Mediso Ltd.
  • Siemens Healthineers
  • Miltenyi Biotec
  • MR Solutions

Recent product launches, imaging software advancements, and AI-enabled analysis platforms are strengthening competitive positioning across the industry.

Key Industry Developments

  • December 2025: Mediso installed its nanoScan 7T PET/MRI preclinical imaging system in the U.S.
  • September 2025: Revvity launched Living Image Synergy AI multimodal analysis software.
  • September 2025: Revvity opened a new In Vivo Imaging Center of Excellence in North Carolina.
  • June 2025: FUJIFILM launched the Vevo F2 LAZR-X20 Photoacoustic Imaging Platform.
  • April 2025: Revvity introduced the VivoJect Image-Guided Injection System.
  • September 2023: Revvity launched the Quantum GX3 microCT imaging platform.

Conclusion

The global preclinical imaging market is positioned for strong growth, increasing from USD 3.42 billion in 2025 to USD 6.85 billion by 2034. Growth is being driven by expanding pharmaceutical R&D activities, rising chronic disease prevalence, increasing adoption of non-invasive imaging technologies, and continuous technological innovation. Advances in AI-powered imaging analysis, multimodal imaging systems, and optical imaging technologies are expected to further strengthen market adoption. With growing investments from pharmaceutical companies, biotechnology firms, research institutes, and CROs, the preclinical imaging market is expected to remain a critical component of future drug discovery and translational research efforts.

Segmentation By Type, Application, End User, and Region

By Type * Hardware

    • Instruments
  • Optical Imaging
  • Nuclear Imaging
  • Micro-MRI Systems
  • Micro-CT Systems
  • Ultrasound Imaging
  • Others
    • Consumables
  • Software

By Application * Oncology

  • Cardiology
  • Neurology
  • Infectious Diseases
  • Others

By End User * Pharmaceutical and Biotechnology Companies

  • Academic & Research Institutes
  • Contract Research Organization (CRO)
  • Others

By Region * North America (By Type, By Application, By End User, and by Country)

    • U.S. (By Application)
    • Canada (By Application)
  • Europe (By Type, By Application, By End User, and by Country/Sub-region)
    • U.K. (By Application)
    • Germany (By Application)
    • France (By Application)
    • Italy (By Application)
    • Spain (By Application)
    • Scandinavia (By Application)
    • Rest of Europe (By Application)
  • Asia Pacific (By Type, By Application, By End User, and by Country/Sub-region)
    • China (By Application)
    • Japan (By Application)
    • India (By Application)
    • Australia (By Application)
    • Southeast Asia (By Application)
    • Rest of Asia Pacific (By Application)
  • Latin America (By Type, By Application, By End User, and by Country/Sub-region)
    • Brazil (By Application)
    • Mexico (By Application)
    • Rest of Latin America (By Application)
  • Middle East & Africa (By Type, By Application, By End User, and by Country/Sub-region)
    • GCC (By Application)
    • South Africa (By Application)
    • Rest of the Middle East & Africa (By Application)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of Clinical Trials, Key Countries/Region, 2025
  • 4.2. Technological Advancements in Preclinical Imaging Devices
  • 4.3. New Product Launches, Key Players
  • 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Preclinical Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Hardware
      • 5.1.1.1. Instruments
        • 5.1.1.1.1. Optical Imaging
        • 5.1.1.1.2. Nuclear Imaging
        • 5.1.1.1.3. Micro-MRI Systems
        • 5.1.1.1.4. Micro-CT Systems
        • 5.1.1.1.5. Ultrasound Imaging
        • 5.1.1.1.6. Others
      • 5.1.1.2. Consumables
    • 5.1.2. Software
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Oncology
    • 5.2.2. Cardiology
    • 5.2.3. Neurology
    • 5.2.4. Infectious Diseases
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Pharmaceutical and Biotechnology Companies
    • 5.3.2. Academic & Research Institutes
    • 5.3.3. Contract Research Organization (CRO)
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Preclinical Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Hardware
      • 6.1.1.1. Instruments
        • 6.1.1.1.1. Optical Imaging
        • 6.1.1.1.2. Nuclear Imaging
        • 6.1.1.1.3. Micro-MRI Systems
        • 6.1.1.1.4. Micro-CT Systems
        • 6.1.1.1.5. Ultrasound Imaging
        • 6.1.1.1.6. Others
      • 6.1.1.2. Consumables
    • 6.1.2. Software
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Oncology
    • 6.2.2. Cardiology
    • 6.2.3. Neurology
    • 6.2.4. Infectious Diseases
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Pharmaceutical and Biotechnology Companies
    • 6.3.2. Academic & Research Institutes
    • 6.3.3. Contract Research Organization (CRO)
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
      • 6.4.1.1. By Application
    • 6.4.2. Canada
      • 6.4.2.1. By Application

7. Europe Preclinical Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Hardware
      • 7.1.1.1. Instruments
        • 7.1.1.1.1. Optical Imaging
        • 7.1.1.1.2. Nuclear Imaging
        • 7.1.1.1.3. Micro-MRI Systems
        • 7.1.1.1.4. Micro-CT Systems
        • 7.1.1.1.5. Ultrasound Imaging
        • 7.1.1.1.6. Others
      • 7.1.1.2. Consumables
    • 7.1.2. Software
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Oncology
    • 7.2.2. Cardiology
    • 7.2.3. Neurology
    • 7.2.4. Infectious Diseases
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Pharmaceutical and Biotechnology Companies
    • 7.3.2. Academic & Research Institutes
    • 7.3.3. Contract Research Organization (CRO)
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. U.K.
      • 7.4.1.1. By Application
    • 7.4.2. Germany
      • 7.4.2.1. By Application
    • 7.4.3. France
      • 7.4.3.1. By Application
    • 7.4.4. Spain
      • 7.4.4.1. By Application
    • 7.4.5. Italy
      • 7.4.5.1. By Application
    • 7.4.6. Scandinavia
      • 7.4.6.1. By Application
    • 7.4.7. Rest of Europe
      • 7.4.7.1. By Application

8. Asia Pacific Preclinical Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Hardware
      • 8.1.1.1. Instruments
        • 8.1.1.1.1. Optical Imaging
        • 8.1.1.1.2. Nuclear Imaging
        • 8.1.1.1.3. Micro-MRI Systems
        • 8.1.1.1.4. Micro-CT Systems
        • 8.1.1.1.5. Ultrasound Imaging
        • 8.1.1.1.6. Others
      • 8.1.1.2. Consumables
    • 8.1.2. Software
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Oncology
    • 8.2.2. Cardiology
    • 8.2.3. Neurology
    • 8.2.4. Infectious Diseases
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Pharmaceutical and Biotechnology Companies
    • 8.3.2. Academic & Research Institutes
    • 8.3.3. Contract Research Organization (CRO)
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. Japan
      • 8.4.1.1. By Application
    • 8.4.2. Australia
      • 8.4.2.1. By Application
    • 8.4.3. China
      • 8.4.3.1. By Application
    • 8.4.4. India
      • 8.4.4.1. By Application
    • 8.4.5. Southeast Asia
      • 8.4.5.1. By Application
    • 8.4.6. Rest of Asia Pacific
      • 8.4.6.1. By Application

9. Latin America Preclinical Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Hardware
      • 9.1.1.1. Instruments
        • 9.1.1.1.1. Optical Imaging
        • 9.1.1.1.2. Nuclear Imaging
        • 9.1.1.1.3. Micro-MRI Systems
        • 9.1.1.1.4. Micro-CT Systems
        • 9.1.1.1.5. Ultrasound Imaging
        • 9.1.1.1.6. Others
      • 9.1.1.2. Consumables
    • 9.1.2. Software
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Oncology
    • 9.2.2. Cardiology
    • 9.2.3. Neurology
    • 9.2.4. Infectious Diseases
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Pharmaceutical and Biotechnology Companies
    • 9.3.2. Academic & Research Institutes
    • 9.3.3. Contract Research Organization (CRO)
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
      • 9.4.1.1. By Application
    • 9.4.2. Mexico
      • 9.4.2.1. By Application
    • 9.4.3. Rest of Latin America
      • 9.4.3.1. By Application

10. Middle East & Africa Preclinical Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Hardware
      • 10.1.1.1. Instruments
        • 10.1.1.1.1. Optical Imaging
        • 10.1.1.1.2. Nuclear Imaging
        • 10.1.1.1.3. Micro-MRI Systems
        • 10.1.1.1.4. Micro-CT Systems
        • 10.1.1.1.5. Ultrasound Imaging
        • 10.1.1.1.6. Others
      • 10.1.1.2. Consumables
    • 10.1.2. Software
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Oncology
    • 10.2.2. Cardiology
    • 10.2.3. Neurology
    • 10.2.4. Infectious Diseases
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Pharmaceutical and Biotechnology Companies
    • 10.3.2. Academic & Research Institutes
    • 10.3.3. Contract Research Organization (CRO)
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
      • 10.4.1.1. By Application
    • 10.4.2. South Africa
      • 10.4.2.1. By Application
    • 10.4.3. Rest of Middle East & Africa
      • 10.4.3.1. By Application

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. FUJIFILM Corporation
    • 11.2.2. Bruker
    • 11.2.3. Revvity
    • 11.2.4. Mediso Ltd.
    • 11.2.5. Siemens Healthineers
    • 11.2.6. Miltenyi Biotec
    • 11.2.7. MILabs B.V.
    • 11.2.8. MR Solutions
    • 11.2.9. Trifoil Imaging LLC
    • 11.2.10. Aspect Imaging Ltd.

List of Tables

  • Figure 1: Global Preclinical Imaging Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Preclinical Imaging Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Preclinical Imaging Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Preclinical Imaging Market Value Share (%), by End User, 2025 & 2034
  • Figure 5: Global Preclinical Imaging Market Value Share (%), by Region, 2025 & 2034
  • Figure 6: North America Preclinical Imaging Market Value (USD billion), by Type, 2025 & 2034
  • Figure 7: North America Preclinical Imaging Market Value Share (%), by Type, 2025
  • Figure 8: North America Preclinical Imaging Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Preclinical Imaging Market Value Share (%), by Application, 2025
  • Figure 10: North America Preclinical Imaging Market Value (USD billion), by End User, 2025 & 2034
  • Figure 11: North America Preclinical Imaging Market Value Share (%), by End User, 2025
  • Figure 12: North America Preclinical Imaging Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Preclinical Imaging Market Value Share (%), By Country, 2025
  • Figure 14: Europe Preclinical Imaging Market Value (USD billion), by Type, 2025 & 2034
  • Figure 15: Europe Preclinical Imaging Market Value Share (%), by Type, 2025
  • Figure 16: Europe Preclinical Imaging Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Preclinical Imaging Market Value Share (%), by Application, 2025
  • Figure 18: Europe Preclinical Imaging Market Value (USD billion), by End User, 2025 & 2034
  • Figure 19: Europe Preclinical Imaging Market Value Share (%), by End User, 2025
  • Figure 20: Europe Preclinical Imaging Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Preclinical Imaging Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Preclinical Imaging Market Value (USD billion), by Type, 2025 & 2034
  • Figure 23: Asia Pacific Preclinical Imaging Market Value Share (%), by Type, 2025
  • Figure 24: Asia Pacific Preclinical Imaging Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Preclinical Imaging Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Preclinical Imaging Market Value (USD billion), by End User, 2025 & 2034
  • Figure 27: Asia Pacific Preclinical Imaging Market Value Share (%), by End User, 2025
  • Figure 28: Asia Pacific Preclinical Imaging Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Preclinical Imaging Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Preclinical Imaging Market Value (USD billion), by Type, 2025 & 2034
  • Figure 31: Latin America Preclinical Imaging Market Value Share (%), by Type, 2025
  • Figure 32: Latin America Preclinical Imaging Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Preclinical Imaging Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Preclinical Imaging Market Value (USD billion), by End User, 2025 & 2034
  • Figure 35: Latin America Preclinical Imaging Market Value Share (%), by End User, 2025
  • Figure 36: Latin America Preclinical Imaging Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Preclinical Imaging Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Preclinical Imaging Market Value (USD billion), by Type, 2025 & 2034
  • Figure 39: Middle East & Africa Preclinical Imaging Market Value Share (%), by Type, 2025
  • Figure 40: Middle East & Africa Preclinical Imaging Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Preclinical Imaging Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Preclinical Imaging Market Value (USD billion), by End User, 2025 & 2034
  • Figure 43: Middle East & Africa Preclinical Imaging Market Value Share (%), by End User, 2025
  • Figure 44: Middle East & Africa Preclinical Imaging Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Preclinical Imaging Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Preclinical Imaging Market Share (%), By Company, 2025